In a study published in Nature, Duke researchers led by Trudy Oliver, PhD, reshape understanding of how small cell lung cancer begins, opening the door to developing therapies that could prevent this aggressive disease.

Duke experts are exploring how natural disasters and other extreme events affect mental and physical health.

Duke's Neuromodulation and Stroke Recovery Lab, led by Wayne Feng, MD, focuses on harnessing non-invasive brain stimulation tools as potential treatment options for post-stroke complications.

Craig Albanese, MD, MBA, will conclude his service at Duke on September 30 to become president of Kaiser Permanente, the nation's largest nonprofit integrated health system.

Aditee Narayan, MD, MPH, vice dean for medical and health professions education at Duke, shares her vision for transforming health care through patient-centered, interdisciplinary health care professions education. From curriculum design to clinical innovation, Dr. Narayan reminds us that educating the next generation is not just a responsibility — it’s an opportunity to shape the future of health.

Duke University School of Medicine study of 170,000 patients found no spike in heart events around daylight saving time, but sleep loss still poses risks for long-term health.

A new review urges routine cannabis screening and careful blood pressure monitoring during surgery, as more evidence shows cannabis can make it harder to safely manage anesthesia.

The seven-year grant will help support the Duke Clinical and Translational Science Institute (CTSI) as it builds and sustains “Trustworthy Partnerships to Improve Health Through Translational Science.”

As a provider who primarily cares for patients living with dementia at the Duke Geriatrics Evaluation and Treatment Clinic, Liza Genao, MD, understands how important it is for patients to feel understood and seen. That understanding motivates her to teach medical Spanish to future doctors.

A followup study of 19 children who received partial heart transplants suggests the procedure pioneered at Duke may have applications as a treatment for a range of pediatric heart valve conditions.